Fund Holdings

Pivotal bioVenture Partners Investment Advisor LLC

Filing Period:
Securities
SharesValue ($K)
Q4 2025
Q1 2026
Change
Q4 2025
Q1 2026
Weight (%)
Change
VAXCYTE INC(PCVX)01,372,425+1,372,425079,751,61728.51%+79,751,617
EVOMMUNE INC01,926,943+1,926,943044,300,42015.83%+44,300,420
AVALO THERAPEUTICS INC0295,933+295,93304,418,2801.58%+4,418,280
TREVI THERAPEUTICS INC(TRVI)01,553,726+1,553,726018,535,9516.63%+18,535,951
BIOAGE LABS INC0653,374+653,374011,427,5114.08%+11,427,511
RALLYBIO CORP0300,579+300,57902,696,1940.96%+2,696,194
MAPLIGHT THERAPEUTICS INC(MPLT)0611,447+611,447012,430,7184.44%+12,430,718
IMMUNOME INC(IMNM)0732,512+732,512016,020,0375.73%+16,020,037
BOLT BIOTHERAPEUTICS INC042,581+42,5810172,0270.06%+172,027
RECURSION PHARMACEUTICALS IN(RXRX)0595,518+595,51801,828,2400.65%+1,828,240
OCULIS HOLDING AG01,680,283+1,680,283044,678,72515.97%+44,678,725
RALLYBIO CORP000000
ARCUTIS BIOTHERAPEUTICS INC(ARQT)01,355,892+1,355,892031,944,81611.42%+31,944,816
ZENAS BIOPHARMA INC(ZBIO)0591,991+591,991011,573,4244.14%+11,573,424
Page 1 of 1